161 related articles for article (PubMed ID: 18619055)
41. Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients.
Peoples GE; Gurney JM; Hueman MT; Woll MM; Ryan GB; Storrer CE; Fisher C; Shriver CD; Ioannides CG; Ponniah S
J Clin Oncol; 2005 Oct; 23(30):7536-45. PubMed ID: 16157940
[TBL] [Abstract][Full Text] [Related]
42. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
43. Time-varying pattern of recurrence risk for Chinese breast cancer patients.
Yin W; Di G; Zhou L; Lu J; Liu G; Wu J; Shen K; Han Q; Shen Z; Shao Z
Breast Cancer Res Treat; 2009 Apr; 114(3):527-35. PubMed ID: 18425576
[TBL] [Abstract][Full Text] [Related]
44. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
45. Prognosis in hormon receptor negative breast cancer patients according to ERBB2 status.
Dogan L; Atalay C; Yilmaz KB; Ozaslan C
Neoplasma; 2008; 55(6):544-8. PubMed ID: 18999885
[TBL] [Abstract][Full Text] [Related]
46. Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer.
Bramwell VH; Doig GS; Tuck AB; Wilson SM; Tonkin KS; Tomiak A; Perera F; Vandenberg TA; Chambers AF
Breast Cancer Res Treat; 2009 Apr; 114(3):503-11. PubMed ID: 18437556
[TBL] [Abstract][Full Text] [Related]
47. Conservative surgery in patients with multifocal/multicentric breast cancer.
Gentilini O; Botteri E; Rotmensz N; Da Lima L; Caliskan M; Garcia-Etienne CA; Sosnovskikh I; Intra M; Mazzarol G; Musmeci S; Veronesi P; Galimberti V; Luini A; Viale G; Goldhirsch A; Veronesi U
Breast Cancer Res Treat; 2009 Feb; 113(3):577-83. PubMed ID: 18330695
[TBL] [Abstract][Full Text] [Related]
48. [Clinicopathological features, prognosis and influence in the adjuvant treatment of the risk recurrence groups determined by the 21 gene expression profile, Oncotype Dx®, in early breast cancer].
Gerson Cwilich R; Alban de la Torre LF; Villalobos Prieto A; Serrano Olvera JA
Gac Med Mex; 2012; 148(2):117-24. PubMed ID: 22622310
[TBL] [Abstract][Full Text] [Related]
49. Changes of serum HER2 status during clinical course of metastatic breast cancer patients.
Fehm T; Jäger W; Kraemer S; Sohn C; Solomayer-Meyberg G; Solomayer EF; Kurek R; Wallwiener D; Gebauer G
Anticancer Res; 2004; 24(6):4205-10. PubMed ID: 15739264
[TBL] [Abstract][Full Text] [Related]
50. Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Peoples GE; Holmes JP; Hueman MT; Mittendorf EA; Amin A; Khoo S; Dehqanzada ZA; Gurney JM; Woll MM; Ryan GB; Storrer CE; Craig D; Ioannides CG; Ponniah S
Clin Cancer Res; 2008 Feb; 14(3):797-803. PubMed ID: 18245541
[TBL] [Abstract][Full Text] [Related]
51. Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients.
Baldini E; Camerini A; Sgambato A; Prochilo T; Capodanno A; Pasqualetti F; Orlandini C; Resta L; Bevilacqua G; Collecchi P
Anticancer Res; 2006; 26(6B):4415-21. PubMed ID: 17201163
[TBL] [Abstract][Full Text] [Related]
52. Breast cancer diagnosis in women < or = 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time.
Zabicki K; Colbert JA; Dominguez FJ; Gadd MA; Hughes KS; Jones JL; Specht MC; Michaelson JS; Smith BL
Ann Surg Oncol; 2006 Aug; 13(8):1072-7. PubMed ID: 16865599
[TBL] [Abstract][Full Text] [Related]
53. The prognostic value of p53 immunostaining in node-negative breast carcinoma.
Soontrapornchai P; Chanvitan A; Koontongkaew S; Sunpaweravong S
J Med Assoc Thai; 2007 Sep; 90(9):1833-8. PubMed ID: 17957927
[TBL] [Abstract][Full Text] [Related]
54. HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients.
Wolstenholme V; Hawkins M; Ashley S; Tait D; Ross G
Breast; 2008 Dec; 17(6):661-5. PubMed ID: 18571923
[TBL] [Abstract][Full Text] [Related]
55. Evidence of poorer survival in pregnancy-associated breast cancer.
Rodriguez AO; Chew H; Cress R; Xing G; McElvy S; Danielsen B; Smith L
Obstet Gynecol; 2008 Jul; 112(1):71-8. PubMed ID: 18591310
[TBL] [Abstract][Full Text] [Related]
56. [The trend of clinical characteristics and prognosis of women's breast cancer 1981 - 2000].
Liu H; Xun P; Chen KX; Li HX; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2405-7. PubMed ID: 18036318
[TBL] [Abstract][Full Text] [Related]
57. Extracellular tumor DNA in plasma and overall survival in breast cancer patients.
Garcia JM; Garcia V; Silva J; Peña C; Dominguez G; Sanchez A; Sanfrutos L; Provencio M; Millan I; Chaparro D; España P; Bonilla F
Genes Chromosomes Cancer; 2006 Jul; 45(7):692-701. PubMed ID: 16607614
[TBL] [Abstract][Full Text] [Related]
58. High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates.
Alexe G; Dalgin GS; Scanfeld D; Tamayo P; Mesirov JP; DeLisi C; Harris L; Barnard N; Martel M; Levine AJ; Ganesan S; Bhanot G
Cancer Res; 2007 Nov; 67(22):10669-76. PubMed ID: 18006808
[TBL] [Abstract][Full Text] [Related]
59. Tumour characteristics among women with very low-risk breast cancer.
Narod SA; Valentini A; Nofech-Mozes S; Sun P; Hanna W
Breast Cancer Res Treat; 2012 Aug; 134(3):1241-6. PubMed ID: 22547106
[TBL] [Abstract][Full Text] [Related]
60. Recurrence pattern and prognosis in low-risk breast cancer patients--data from the DBCG 89-A programme.
Christiansen P; Al-Suliman N; Bjerre K; Møller S;
Acta Oncol; 2008; 47(4):691-703. PubMed ID: 18465337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
